Literature DB >> 8301634

Effects of lidocaine and calcitonin gene-related peptide (CGRP) on isolated human radial arteries.

J Jernbeck1, U E Samuelson.   

Abstract

Vasoconstriction during and after microsurgery may cause hypoperfusion and result in flap necrosis. This study investigated the vascular effects of two known vasodilators: lidocaine and the naturally-occurring substance, calcitonin gene-related peptide (CGRP). Experiments were performed in vitro on 47 human radial arterial rings from 18 patients undergoing reconstruction after head and neck tumor surgery with free radial forearm flaps. Lidocaine produced a biphasic dose-response curve, with contraction at low concentrations (1.5 x 10(-5) to 1.5 x 10(-3) M) and relaxation at higher concentrations (4.5 x 10(-3) to 1.5 x 10(-2) M). It caused significantly stronger contractions in arteries with mechanically removed endothelium, compared with arteries with intact endothelium. Prolonged rebound contraction occurred when the lidocaine concentration was decreased. Lidocaine also potentiated noradrenaline-induced contraction. CGRP produced only dose-dependent relaxation of constricted radial arteries at low concentrations (3 x 10(-10) to 10(-7) M). The contractile effects of lidocaine should be considered when a vasodilative substance is required.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8301634     DOI: 10.1055/s-2007-1006743

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  2 in total

1.  Lidocaine relaxation in isolated rat aortic rings is enhanced by endothelial removal: possible role of Kv, KATP channels and A2a receptor crosstalk.

Authors:  Aryadi Arsyad; Geoffrey P Dobson
Journal:  BMC Anesthesiol       Date:  2016-12-03       Impact factor: 2.217

2.  Systemic nicardipine as an adjunct to combat vasospasm after prior flap failure.

Authors:  Brett F Michelotti; Samer Rajjoub; T Shane Johnson
Journal:  Plast Reconstr Surg Glob Open       Date:  2013-11-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.